This is a prospective open-label multicenter trial in which the objective is to evaluate levonorgestrel as the only method of emergency contraception. Levonorgestrel 0.75 was administered as 2 doses of 1 tablet each given 12 hours apart to qualifying women who presented within 72 hours after unprotected intercourse. Subjects will be followed until their next menstrual period.
Showing the most recent 10 out of 859 publications